Is It Time to Sell MercadoLibre?
MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…
Buy
59
MAZE Quote, Financials, Valuation and Earnings
Last price:
$13.83
Seasonality move
:
--
Day range:
$13.03 - $14.40
52-week range:
$6.71 - $17.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
95.6K
Avg. volume:
162.4K
1-year change:
--
Market cap:
$594M
Revenue:
--
EPS (TTM):
--
Earnings Data
Next earnings date for MAZE
Aug 29
2025
Most recent earnings per share
-$0.06
Missed by $0.06
(Sep 30/2024)
Consensus Estimate
--
(Sep 30/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MAZE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/29/2025 | Q2 | $3.1M | -- | -- | -$0.95 | -- |
| 05/14/2025 | Q1 | -- | -- | -- | -$0.63 | -- |
| 03/31/2025 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2024 | Q3 | -- | $2.5M | -$0.06 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.08 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.07 | -- | -- |
Maze Therapeutics Earnings Questions
-
How Much did Maze Therapeutics Generate in Revenue Last Quarter?
Maze Therapeutics reported $2.5M worth of top line sales in its most recent quarter.
-
Did Maze Therapeutics Beat Earnings Last Quarter?
Maze Therapeutics announced earnings per share of -$0.06 which represents a miss of analyst forecast a -- per share.
-
Is Maze Therapeutics Profitable?
Maze Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Maze Therapeutics EPS Next Year?
Maze Therapeutics's earnings are forecast to decrease from -- per share to -$20.10 per share next year representing a decrease of -1131.57%.
-
When is Maze Therapeutics's Earnings Date?
Maze Therapeutics's next earnings date is August 29, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock High Risk or High Reward?
EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…
Why Did Chase Coleman Buy TSM?
Billionaire Chase Coleman of Tiger Global Management has built a…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 48x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
76
SBET alert for Jun 5
SharpLink Gaming [SBET] is down 5.56% over the past day.
Buy
80
GWRE alert for Jun 5
Guidewire Software [GWRE] is up 1.81% over the past day.
Buy
70
ZLAB alert for Jun 5
Zai Lab [ZLAB] is up 1.61% over the past day.
